Cassava Sciences Inc (SAVA)
21.73
+0.99
(+4.77%)
USD |
NASDAQ |
Apr 25, 16:00
22.20
+0.47
(+2.16%)
After-Hours: 07:14
Cassava Sciences Cash from Investing (TTM): -0.414M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.414M |
September 30, 2023 | -0.038M |
June 30, 2023 | -1.172M |
March 31, 2023 | -2.644M |
December 31, 2022 | -2.712M |
September 30, 2022 | -3.147M |
June 30, 2022 | -24.03M |
March 31, 2022 | -22.64M |
December 31, 2021 | -22.21M |
September 30, 2021 | -22.11M |
June 30, 2021 | -0.073M |
March 31, 2021 | 0.26M |
December 31, 2020 | 0.36M |
September 30, 2020 | 0.36M |
June 30, 2020 | 0.36M |
March 31, 2020 | 0.10M |
December 31, 2019 | -0.018M |
September 30, 2019 | -0.018M |
June 30, 2019 | -0.018M |
March 31, 2019 | -0.018M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 2.101M |
Date | Value |
---|---|
September 30, 2017 | 0.557M |
June 30, 2017 | -0.068M |
March 31, 2017 | 1.432M |
December 31, 2016 | -2.166M |
September 30, 2016 | 0.278M |
June 30, 2016 | 0.954M |
March 31, 2016 | 0.505M |
December 31, 2015 | -0.192M |
September 30, 2015 | 0.009M |
June 30, 2015 | -0.893M |
March 31, 2015 | -0.943M |
December 31, 2014 | 1.172M |
September 30, 2014 | 0.122M |
June 30, 2014 | 0.974M |
March 31, 2014 | 1.474M |
December 31, 2013 | 5.656M |
September 30, 2013 | 3.00M |
June 30, 2013 | 13.52M |
March 31, 2013 | 19.02M |
December 31, 2012 | 17.62M |
September 30, 2012 | 22.73M |
June 30, 2012 | 22.21M |
March 31, 2012 | 20.21M |
December 31, 2011 | 59.90M |
September 30, 2011 | 44.08M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-24.03M
Minimum
Jun 2022
0.36M
Maximum
Jun 2020
-5.253M
Average
-0.073M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
Amylyx Pharmaceuticals Inc | 92.05M |
MannKind Corp | -1.988M |
Clearside Biomedical Inc | -1.777M |
Lantern Pharma Inc | -0.9302M |
NovaBay Pharmaceuticals Inc | -0.019M |